NOVARTIS PHARMS CORP N 31835Letterhttp://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/022059Orig1s013ltr.pdf0220590132/14/2012 12:00:00 AMSLRLabeling Revision022059001TABLET;ORALEQ 250MG BASE11TYKERBLAPATINIB DITOSYLATE